SCHEMBL7212816

SCHEMBL7212816

CC(C)c1cc(C(C)C)c(CS(=O)(=O)c2c(C(C)C)cccc2C(C)C)c(C(C)C)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOAT2 O75908 1/20 0.47
MYC P01106 1/20 0.47
SOAT1 P35610 1/20 0.47
MAP2K3 P46734 1/20 0.47
FABP4 P15090 4/20 0.46
FABP3 P05413 2/20 0.46
FABP5 Q01469 1/20 0.46
TDP1 Q9NUW8 1/20 0.39
GABRA1 P14867 3/20 0.38
GABRG2 P18507 2/20 0.38
GABRB3 P28472 2/20 0.38
NR3C1 P04150 1/20 0.36
GAA P10253 1/20 0.35
PDE4B Q07343 1/20 0.35
ALDH1A1 P00352 1/20 0.35
F10 P00742 1/20 0.34
GABRB2 P47870 2/20 0.33
FAAH O00519 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11068103 0.75 FABP4 (0.50) SOAT2MYCSOAT1MAP2K3FABP4
SCHEMBL8879223 0.74 FABP4 (0.48) SOAT2MYCSOAT1MAP2K3FABP4
SCHEMBL4246719 0.73 FABP4 (0.62) SOAT2MYCSOAT1MAP2K3FABP4
SCHEMBL5456119 0.72 SOAT2 (0.67) SOAT2MYCSOAT1MAP2K3FABP4
SCHEMBL5475540 0.72 SOAT2 (0.46) SOAT2MYCSOAT1MAP2K3FABP4
SCHEMBL14874598 0.71 FABP4 (0.46) SOAT2MYCSOAT1MAP2K3FABP4
SCHEMBL7109175 0.71 SOAT2 (0.59) SOAT2MYCSOAT1MAP2K3
SCHEMBL5471770 0.71 SOAT2 (0.65) SOAT2MYCSOAT1MAP2K3FABP4
SCHEMBL5458696 0.70 SOAT2 (0.44) SOAT2MYCSOAT1MAP2K3FABP4
SCHEMBL24682303 0.69 FABP4 (0.56) SOAT2MYCSOAT1MAP2K3FABP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0841913-B1 USE OF SULFAMIC ACID DERIVATIVES, ACYL SULFONAMIDES OR SULFONYL CARBAMATES FOR THE MANUFACTURE OF A MEDICAMENT FOR LOWERING LIPOPROTEIN LEVELS WARNER LAMBERT CO (US) 2003-02-05 EP claimed